Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection
- PMID: 11268972
Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection
Abstract
Background/aims: Few studies have assessed the significance of prognostic factors in cirrhotic patients undergoing resection for hepatocellular carcinoma.
Methodology: Overall survival and disease-free survival were evaluated in 53 cirrhotic patients undergoing hepatic resection for supervening hepatocellular carcinoma. The value of the UICC TNM classification, and the Izumi modified staging system on prognosis were analyzed.
Results: In multivariate analysis lack of micro/macrovascular invasion were predictive for long-term outcome. The difference between stages 1 and 2 or stage 3 and 4A using the UICC TNM classification was not significant with respect to survival or disease-free survival. UICC TNM classification was modified as follows; stage 1, solitary tumor without vascular invasion; stage 2, solitary or multiple tumor(s) involving adjacent vessel branch; stage 3, tumor(s) involving major vessel branch or with regional lymph node metastases; stage 4, tumor(s) with distant metastases. TNM (modified in accordance with Izumi) showed a significant difference between each stage with respect to survival and disease-free survival.
Conclusions: A uniform tumor classification of hepatocellular carcinoma is advocated. Our results show that the UICC TNM classification for hepatocellular carcinoma is inadequate and may even on occasion lead to unnecessary resection. The modified staging system of Izumi is superior in determining outcome for cirrhotic patients with supervening hepatocellular carcinoma undergoing resection.
Similar articles
-
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients.Eur J Surg Oncol. 2005 Sep;31(7):760-7. doi: 10.1016/j.ejso.2005.04.008. Eur J Surg Oncol. 2005. PMID: 15975760
-
LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.J Surg Res. 2010 Mar;159(1):538-44. doi: 10.1016/j.jss.2008.09.004. Epub 2008 Oct 7. J Surg Res. 2010. PMID: 19111323
-
Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.J Am Coll Surg. 2006 Oct;203(4):426-35. doi: 10.1016/j.jamcollsurg.2006.06.030. Epub 2006 Aug 23. J Am Coll Surg. 2006. PMID: 17000385
-
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178. J Surg Oncol. 2002. PMID: 12451624 Review.
-
[Prognostic factors in liver tumors].Verh Dtsch Ges Pathol. 1995;79:109-15. Verh Dtsch Ges Pathol. 1995. PMID: 8600673 Review. German.
Cited by
-
Serum sIL-2R, TNF-alpha and IFN-gamma in alveolar echinococcosis.World J Gastroenterol. 2004 Dec 15;10(24):3674-6. doi: 10.3748/wjg.v10.i24.3674. World J Gastroenterol. 2004. PMID: 15534930 Free PMC article.
-
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.Ann Surg. 2007 Jun;245(6):909-22. doi: 10.1097/01.sla.0000254368.65878.da. Ann Surg. 2007. PMID: 17522517 Free PMC article.
-
Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma.World J Gastroenterol. 2008 Aug 21;14(31):4915-22. doi: 10.3748/wjg.14.4915. World J Gastroenterol. 2008. PMID: 18756600 Free PMC article.
-
Small hepatocellular carcinoma: current and future approaches.Hepatol Int. 2013 Jul;7(3):805-12. doi: 10.1007/s12072-013-9454-z. Epub 2013 Aug 6. Hepatol Int. 2013. PMID: 26201917
MeSH terms
LinkOut - more resources
Medical